TSX-V:SGMD - TSX Venture Exchange - CA79549X1096 - Common Stock - Currency: CAD
TSX-V:SGMD (3/20/2024, 7:00:00 PM)
0.21
-0.01 (-2.33%)
The current stock price of SGMD.CA is 0.21 CAD. In the past month the price increased by 20%. In the past year, price decreased by -40%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 297.70M | ||
MIR.CA | MEDMIRA INC | N/A | 79.62M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 61.95M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 50.50M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 33.97M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 28.76M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 27.68M | ||
ASG.CA | AURORA SPINE CORP | N/A | 24.90M | ||
MDX.CA | MEDX HEALTH CORP | N/A | 17.70M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 15.91M | ||
EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 4.81M |
Salona Global Medical Device Corp. engages in the provision of financial and consultancy services to the mental health and addiction industry. The company is headquartered in Carlsbad, California and currently employs 144 full-time employees. The company went IPO on 2014-03-28. Through strategic acquisitions, it leverages the intellectual properties of specialized companies to deliver products and services through its subsidiaries. The company develops, manufactures, and sells medical devices, some of which are proprietary and white labels. Its products include devices used for pain management and physical therapy treatments, including cold/hot therapy products, neuromuscular electrical stimulation devices, transcutaneous electrical nerve stimulation devices, ultrasound treatment devices, as well as wearable technology and other products used for prevention, treatment, and rehabilitation of the human body. Its operations are focused predominantly on the business of recovery science, technologies that help individuals recover from surgery and prevent disease. Its subsidiaries consist of South Dakota Partners, Inc., Simbex, LLC, ALG Health Plus, LLC and others.
SALONA GLOBAL MEDICAL DEVICE
6160 Innovation Way
Carlsbad CALIFORNIA US
CEO: Jaime Gerber
Employees: 144
Company Website: https://www.salonaglobal.com/
Phone: 18007606826
The current stock price of SGMD.CA is 0.21 CAD. The price decreased by -2.33% in the last trading session.
The exchange symbol of SALONA GLOBAL MEDICAL DEVICE is SGMD and it is listed on the TSX Venture Exchange exchange.
SGMD.CA stock is listed on the TSX Venture Exchange exchange.
5 analysts have analysed SGMD.CA and the average price target is 1.17 CAD. This implies a price increase of 458.57% is expected in the next year compared to the current price of 0.21. Check the SALONA GLOBAL MEDICAL DEVICE stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SALONA GLOBAL MEDICAL DEVICE (SGMD.CA) has a market capitalization of 11.97M CAD. This makes SGMD.CA a Nano Cap stock.
SALONA GLOBAL MEDICAL DEVICE (SGMD.CA) currently has 144 employees.
SALONA GLOBAL MEDICAL DEVICE (SGMD.CA) has a support level at 0.2 and a resistance level at 0.21. Check the full technical report for a detailed analysis of SGMD.CA support and resistance levels.
The Revenue of SALONA GLOBAL MEDICAL DEVICE (SGMD.CA) is expected to grow by 83.45% in the next year. Check the estimates tab for more information on the SGMD.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SGMD.CA does not pay a dividend.
SALONA GLOBAL MEDICAL DEVICE (SGMD.CA) will report earnings on 2022-01-20.
SALONA GLOBAL MEDICAL DEVICE (SGMD.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.3).
ChartMill assigns a technical rating of 1 / 10 to SGMD.CA. When comparing the yearly performance of all stocks, SGMD.CA is a bad performer in the overall market: 75.48% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to SGMD.CA. Both the profitability and financial health of SGMD.CA have multiple concerns.
Over the last trailing twelve months SGMD.CA reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS decreased by -3.07% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -23.11% | ||
ROE | -80.88% | ||
Debt/Equity | 0.83 |
ChartMill assigns a Buy % Consensus number of 80% to SGMD.CA. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of -50% and a revenue growth 83.45% for SGMD.CA